Perez A - Search Results

1

Effect of L-asparaginase on insulin secretion from isolated rat islets of Langerhans.

Pou JM, Cervera T, Perez A, Ortiz MA, Arroyo JA. Pou JM, et al. Among authors: perez a. Horm Res. 1991;35(3-4):155-60. doi: 10.1159/000181893. Horm Res. 1991. PMID: 1725285

2

Lipoprotein(a) concentrations and non-insulin-dependent diabetes mellitus: relationship to glycaemic control and diabetic complications.

Chico A, Pérez A, Caixàs A, Ordóñez J, Pou JM, de Leiva A. Chico A, et al. Among authors: perez a. Diabetes Res Clin Pract. 1996 Jul;33(2):105-10. doi: 10.1016/0168-8227(96)01285-5. Diabetes Res Clin Pract. 1996. PMID: 8879965

3

Lipoprotein compositional abnormalities in type I diabetes: effect of improved glycaemic control.

Pérez A, Caixàs A, Carreras G, Mauricio D, Pou JM, Serrat J, Gómez-Gerique J, de Leiva A. Pérez A, et al. Diabetes Res Clin Pract. 1997 May;36(2):83-90. doi: 10.1016/s0168-8227(97)00033-8. Diabetes Res Clin Pract. 1997. PMID: 9229192

4

Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.

Pérez A, Wägner AM, Carreras G, Giménez G, Sánchez-Quesada JL, Rigla M, Gómez-Gerique JA, Pou JM, de Leiva A. Pérez A, et al. Arch Intern Med. 2000 Oct 9;160(18):2756-62. doi: 10.1001/archinte.160.18.2756. Arch Intern Med. 2000. PMID: 11025785

5

Physical training decreases plasma thrombomodulin in type I and type II diabetic patients.

Rigla M, Fontcuberta J, Mateo J, Caixàs A, Pou JM, de Leiva A, Pérez A. Rigla M, et al. Among authors: perez a. Diabetologia. 2001 Jun;44(6):693-9. doi: 10.1007/s001250051677. Diabetologia. 2001. PMID: 11440361

6

Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes.

Albareda M, Rigla M, Rodríguez-Espinosa J, Caballero A, Chico A, Cabezas R, Carreras G, Pérez A. Albareda M, et al. Among authors: perez a. Diabetes Res Clin Pract. 2005 Jun;68(3):202-6. doi: 10.1016/j.diabres.2004.10.005. Epub 2004 Dec 8. Diabetes Res Clin Pract. 2005. PMID: 15936461 Clinical Trial.

7

Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control.

Sánchez-Quesada JL, Pérez A, Caixàs A, Ordónmez-Llanos J, Carreras G, Payés A, González-Sastre F, de Leiva A. Sánchez-Quesada JL, et al. Among authors: perez a. Diabetologia. 1996 Dec;39(12):1469-76. doi: 10.1007/s001250050600. Diabetologia. 1996. PMID: 8960828

8

Lack of change of lipoprotein(a) levels by the optimization of glycemic control with insulin therapy in NIDDM patients.

Caixas A, Pérez A, Qrdóñez-Llanos J, Bonet R, Rigla M, Castellví A, Bayen L, de Leiva A. Caixas A, et al. Among authors: perez a. Diabetes Care. 1997 Sep;20(9):1459-61. doi: 10.2337/diacare.20.9.1459. Diabetes Care. 1997. PMID: 9283797

9

Plasma lipoprotein(a) levels are not influenced by glycemic control in type 1 diabetes.

Pérez A, Carreras G, Caixàs A, Castellví A, Caballero A, Bonet R, Ordóñez-Llanos J, de Leiva A. Pérez A, et al. Diabetes Care. 1998 Sep;21(9):1517-20. doi: 10.2337/diacare.21.9.1517. Diabetes Care. 1998. PMID: 9727901

10

Effects of a short-acting insulin analog (Insulin Lispro) versus regular insulin on lipid metabolism in insulin-dependent diabetes mellitus.

Caixàs A, Pérez A, Payés A, Otal C, Carreras G, Ordóñez-Llanos J, Reviriego J, Anderson JH, de Leiva A. Caixàs A, et al. Among authors: perez a. Metabolism. 1998 Apr;47(4):371-6. doi: 10.1016/s0026-0495(98)90045-2. Metabolism. 1998. PMID: 9580247 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,600 results

Search Page

Filters